This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Friday's Small-Cap Winners & Losers

Small-cap stocks surged higher than the cheery broad market Friday, and ShengdaTech (SDTH) was among the biggest gainers, soaring 22% on solid 2007 guidance.

The China-based company, which makes nano-precipitated calcium carbonate and coal-based chemicals, expects a profit of 43 cents to 45 cents a share on revenue ranging between $96 million and $98 million. The analyst who follows the company is seeking 43 cents a share on $95.9 million in sales, according to Thomson Financial. Shares added $1.03 to $5.72.

Silverleaf Resorts (SVLF), meanwhile, upped its own full-year outlook. The Dallas-based timeshare operator now expects to make 70 cents to 72 cents a share, or $27.5 million to $28.5 million. Prior guidance had earnings at $25.5 million. Shares climbed 12.6% to $5.29.

Coinmach Service (DRA), a laundry-equipment-services company based in Plainview, N.Y., was also higher on news it will sell itself to investment firm Babcock & Brown for $1.33 billion in cash, including debt assumption. The deal, which will probably close in the third quarter, values shares at $13.55 apiece -- a 15.7% premium to Thursday's closing price.

Coinmach shares leapt 13.3% to $13.27 in support of the Russell 2000, which was lately soaring 1.3% along with the S&P SmallCap 600.

But among the scarce small-cap losers was a component of both indices -- leaf-tobacco purveyor Alliance One International (AOI - Get Report). Shares slid 8.2% after fiscal fourth-quarter revenue plunged 25.5% to $433.2 million, while 2007 sales, at $1.98 billion, came in below the only analyst's forecast. Despite also topping the sole full-year income estimate, the Morrisville, N.C., company lately traded at $10.68.

And China's Simcere Pharmaceutical (SCR) fell 6% to $14.86 on word it will buy another 10% equity stake in Shandong Simcere Medgenn Bio-Pharmaceutical for $3.5 million (26.8 million yuan), a move that will give it 90% total ownership.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AOI $24.76 2.74%
DRA $16.18 -0.43%
AAPL $95.03 -2.90%
FB $116.73 7.20%
GOOG $691.02 -2.10%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs